ZI-MA4-1 (TCR-NK cells) + Cyclophosphamide + FLUDARABINE

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

ZI-MA4-1 (TCR-NK cells) + Cyclophosphamide + FLUDARABINE
Treatment and conditionWhere it standsTrials
ZI-MA4-1 (TCR-NK cells) + Cyclophosphamide + FLUDARABINE for head and neck neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
ZI-MA4-1 (TCR-NK cells) + Cyclophosphamide + FLUDARABINE for sarcoma, synovialPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1